993
Views
1
CrossRef citations to date
0
Altmetric
Articles; Medical Biotechnology

Impact of IL-10 and IL-12B single nucleotide polymorphisms on circulating cytokine level in development of Hashimoto's thyroiditis

, &
Pages 713-720 | Received 27 Oct 2015, Accepted 30 Mar 2016, Published online: 21 Apr 2016

Figures & data

Figure 1. Distribution of allele and genotype frequencies of 3’UTR A/C in IL12B among Hashimoto's thyroiditis (HT) patients and healthy subjects (C).

Figure 1. Distribution of allele and genotype frequencies of 3’UTR A/C in IL12B among Hashimoto's thyroiditis (HT) patients and healthy subjects (C).

Table 1. Serum concentrations of IL-12p40 and IL-10 in Hashimoto's thyroiditis (HT) patients and healthy controls.

Figure 2. Serum levels of IL-12p40 in Hashimoto's thyroiditis (HT) patients and controls (C). EU – patients in euthyroid stage; HYPO – patients with hypothyroidism; TREATMENT – patients treated with levothyroxine. Results are presented as mean values with standard errors of the means (±SEМ).

Figure 2. Serum levels of IL-12p40 in Hashimoto's thyroiditis (HT) patients and controls (C). EU – patients in euthyroid stage; HYPO – patients with hypothyroidism; TREATMENT – patients treated with levothyroxine. Results are presented as mean values with standard errors of the means (±SEМ).

Figure 3. Serum levels of IL-12p40 in Hashimoto's thyroiditis (HT) patients and controls (C) according to the genotypes of the 3’UTR A/C IL12B polymorphism. Results are presented as means ±SEМ.

Figure 3. Serum levels of IL-12p40 in Hashimoto's thyroiditis (HT) patients and controls (C) according to the genotypes of the 3’UTR A/C IL12B polymorphism. Results are presented as means ±SEМ.

Figure 4. Serum levels of IL-10 in Hashimoto's thyroiditis (HT) patients and controls (C). EU – patients in euthyroid stage; HYPO – patients with hypothyroidism; TREATMENT – patients treated with levothyroxine. Results are presented as means ±SEМ.

Figure 4. Serum levels of IL-10 in Hashimoto's thyroiditis (HT) patients and controls (C). EU – patients in euthyroid stage; HYPO – patients with hypothyroidism; TREATMENT – patients treated with levothyroxine. Results are presented as means ±SEМ.

Figure 5. Serum levels of IL-10 in Hashimoto's thyroiditis (HT) patients (EU – patients in euthyroid stage; HYPO – patients with hypothyroidism) according to the −1082 A/G IL10 SNP genotypes. Results are presented as means values ±SEМ.

Figure 5. Serum levels of IL-10 in Hashimoto's thyroiditis (HT) patients (EU – patients in euthyroid stage; HYPO – patients with hypothyroidism) according to the −1082 A/G IL10 SNP genotypes. Results are presented as means values ±SEМ.

Figure 6. Distribution of allele and genotype frequencies of −1082 A/G in IL-10 among Hashimoto's thyroiditis (HT) patients and healthy subjects (C).

Figure 6. Distribution of allele and genotype frequencies of −1082 A/G in IL-10 among Hashimoto's thyroiditis (HT) patients and healthy subjects (C).